Who owns Sellas Life Sciences Group I?
- Ticker: SLS
- CUSIP Number: 81642t209
Tip: Access positions for across all investors
Analyze quarterly positions in Sellas Life Sciences Group I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sellas Life Sciences Group I stock
Who bought or sold Sellas Life Sciences Group I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Alyeska Investment Group | 1.3M | $1.4M | -22% | Dec 2023 |
|
| Vanguard Group | 1.1M | $1.2M | 11% | Dec 2023 |
|
| Citadel Advisors | 281k | $298k | 3% | Dec 2023 |
|
| Opus Capital Group | 201k | $203k | 49% | Mar 2024 |
|
| Virtu Financial | 60k | $64k | 216% | Dec 2023 |
|
| Wells Fargo & Company | 16k | $17k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 16k | $17k | 0% | Dec 2023 |
|
| Two Sigma Securities | 15k | $16k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 14k | $14k | 13% | Mar 2024 |
|
| Millennium Management | 11k | $12k | 100% | Dec 2023 |
|
| Brooklyn FI | 11k | $11k | 100% | Mar 2024 |
|
| Nemes Rush Group | 10k | $11k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 9.8k | $10k | 143% | Dec 2023 |
|
| Advisor Group Holdings | 1.7k | $1.8k | -50% | Dec 2023 |
|
| Royal Bank of Canada | 358.00 | $0 | 79% | Dec 2023 |
|
| Hanson McClain Advisors | 150.00 | $151.995000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 42.00 | $43.999200 | 100% | Dec 2023 |
|
| JJJ Advisors | 11.00 | $11.999900 | 0% | Mar 2024 |
|
| Parkside Financial Bank & Trust | 2.00 | $3.000000 | 0% | Mar 2024 |
|
Who sold out of Sellas Life Sciences Group I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of New York Mellon | Dec 2023 | 85k | $90k |
| Jane Street | Sep 2023 | 11k | $18k |
| UBS Group | Sep 2023 | 26.00 | $42.998800 |